Successful Treatment of ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis in a Patient with Small Lymphocytic Lymphoma (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1251; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Rapid protein clearance contributes to minimal immune deposits on routine immunofluorescence. The effectiveness of Venetoclax, Rituximab combined with a C5a receptor antagonist, Avacopan supports complement-mediated injury as a key mechanism in SLL/CLL associated seronegative PIGN."
Clinical • ANCA Vasculitis • Antibody-mediated Rejection • Chronic Lymphocytic Leukemia • Glomerulonephritis • Hematological Malignancies • Infectious Disease • Leukemia • Lupus Nephritis • Lymphoma • Nephrology • Non-Hodgkin's Lymphoma • Renal Disease • Small Lymphocytic Lymphoma • Vasculitis • A2M • CD20
|
|
Lakan S. Cortez; Emily H. Park; Lyndsey Reich; Hussain A. Gilani; Oleg I. Krijanovski; Alexander Weickhardt
|